SNP ID | Position | Alleles | Trait | Variation Type |
---|---|---|---|---|
rs10037670 | chr5:154431930 (GRCh38.p7) | A>G | alcohol dependence | SNV(Single Nucleotide Variation) |
Gene Symbol | Pearson Correlation Coefficient |
---|---|
KDM5A | 0.591 |
PHC3 | 0.585 |
SPATA5 | 0.58 |
ALMS1 | 0.578 |
PCDHGB3 | 0.567 |
NFATC3 | 0.555 |
ZNF234 | 0.553 |
ZNF264 | 0.546 |
CD160 | 0.546 |
RAET1E | 0.541 |
Gene Symbol | Pearson Correlation Coefficient |
---|---|
CRH | -0.328 |
TMEM253 | -0.317 |
SPEF1 | -0.29 |
BHLHA9 | -0.283 |
PARD6A | -0.276 |
PRTN3 | -0.272 |
GSG1 | -0.266 |
CORT | -0.264 |
ADRA2C | -0.259 |
GGN | -0.255 |
ID | Drug Name | Action | PubMed |
---|---|---|---|
C018475 | butyraldehyde | butyraldehyde results in decreased expression of SAP30L-AS1 mRNA | 26079696 |
D002945 | Cisplatin | [Cisplatin co-treated with jinfukang] results in decreased expression of SAP30L-AS1 mRNA | 27392435 |
C118739 | entinostat | entinostat results in increased expression of SAP30L-AS1 mRNA | 27188386 |
C544151 | jinfukang | [Cisplatin co-treated with jinfukang] results in decreased expression of SAP30L-AS1 mRNA | 27392435 |
C561695 | (+)-JQ1 compound | (+)-JQ1 compound results in increased expression of SAP30L-AS1 mRNA | 22904298|2675264 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|
KEGG ID | KEGG Term |
---|
Reactome ID | Reactome Term | Evidence |
---|
PMID | Title (Year) | Author | Journal |
---|